Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1948 1
1950 1
1951 17
1952 1
1954 1
1957 1
1958 3
1959 2
1960 1
1961 3
1965 1
1966 1
1968 2
1970 1
1972 5
1973 4
1975 1
1976 3
1977 1
1978 2
1979 1
1981 1
1982 1
1983 2
1984 2
1985 1
1986 1
1988 1
1989 2
1990 4
1991 2
1992 4
1993 2
1994 2
1995 3
1996 2
1997 5
1998 6
1999 7
2000 11
2001 7
2002 7
2003 7
2004 13
2005 17
2006 16
2007 14
2008 23
2009 27
2010 34
2011 29
2012 30
2013 41
2014 40
2015 58
2016 56
2017 53
2018 60
2019 65
2020 71
2021 70
2022 70
2023 76
2024 76
2025 77
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

991 results

Results by year

Filters applied: . Clear all
Page 1
Tobacco and nicotine use.
Le Foll B, Piper ME, Fowler CD, Tonstad S, Bierut L, Lu L, Jha P, Hall WD. Le Foll B, et al. Nat Rev Dis Primers. 2022 Mar 24;8(1):19. doi: 10.1038/s41572-022-00346-w. Nat Rev Dis Primers. 2022. PMID: 35332148 Review.
Amylin brain circuitry.
Boccia L, Gamakharia S, Coester B, Whiting L, Lutz TA, Le Foll C. Boccia L, et al. Peptides. 2020 Oct;132:170366. doi: 10.1016/j.peptides.2020.170366. Epub 2020 Jul 4. Peptides. 2020. PMID: 32634450 Free article. Review.
Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.
Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-Ladner U, Niehues T, Überla K, Vygen-Bonnet S, Weinke T, Wiese-Posselt M, Wojcinski M, Zepp F. Wagner N, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019. PMID: 30899964 German. No abstract available.
The authors reply.
Massart N, Flecher E, Auffret V, Ross JT, Mansour A, Nesseler N. Massart N, et al. Crit Care Med. 2022 Jun 1;50(6):e607-e608. doi: 10.1097/CCM.0000000000005542. Epub 2022 May 19. Crit Care Med. 2022. PMID: 35612456 No abstract available.
Monitoring the impact of cannabis use.
Le Foll B. Le Foll B. Trends Psychiatry Psychother. 2022 Jul 14;44(suppl 1):e20210462. doi: 10.47626/2237-6089-2021-0462. Trends Psychiatry Psychother. 2022. PMID: 35081301 Free PMC article. No abstract available.
Cannabis use disorder: from neurobiology to treatment.
Le Foll B, Tang VM, Rueda S, Trick LV, Boileau I. Le Foll B, et al. J Clin Invest. 2024 Oct 15;134(20):e172887. doi: 10.1172/JCI172887. J Clin Invest. 2024. PMID: 39403927 Free PMC article. Review.
Cannabinoids: Friend or foe?
Le Foll B, Tyndale RF. Le Foll B, et al. Clin Pharmacol Ther. 2015 Jun;97(6):528-31. doi: 10.1002/cpt.119. Clin Pharmacol Ther. 2015. PMID: 25801347 Free PMC article.
991 results